Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$71,000.00

Intergrated biochemical genomics and cellular platform for alkaloid biosynthetic gene discovery and characterization

EF 2012-13

Résumé
The unparalleled biosynthetic capacity of plants has long been exploited through the use of many species in traditional medicine and the application of pure metabolites as pharmaceuticals, flavours, fragrances, pigments, insecticides, and other fine chemicals. Benzylisoquinoline alkaloids (BIAs) are a large group of plant specialized metabolites derived from tyrosine and diversified by an intricate biochemical network of intramolecular coupling, reduction, methylation, hydroxylation, and other reactions that generate >2,500 known structures. Several BIAs (e.g. the analgesic morphine, the cough suppressant codeine, and the vasodilators papaverine and tubocurarine) serve directly as pharmaceuticals, or as precursors for semi-synthetic drugs (e.g. oxycodone). Plants remain the only economical source for these compounds due to their chemical complexity, which makes de novo synthesis challenging and costly. Most research on BIA metabolism has targeted biosynthetic enzymes and corresponding genes involved in the formation of relatively few compounds in only a limited number of species. An important feature of plant specialized metabolism is the ability of enzymes to acquire novel functions through random mutation. As such, a relatively limited number of enzyme types (i.e. SAM-dependent methyltransferases, acetylCoA-dependent acyltransferases, P450-dependent monooxygenases, FAD-dependent oxidoreductases, short-chain dehydrogenase/reductases and aldo-keto reductases) are largely responsible for the establishment of the diverse backbone structures and functional group substitutions responsible for BIA structural diversity. A functional genomics strategy based on the integration and comparison of metabolite and transcript profiles from a collection of cultured plant species will be used to identify and characterize novel BIA biosynthetic enzymes. Genomics resources and molecular genetic tools will be used to identify and modulate transcription factors involved in the regulation of BIA metabolism. The cellular and subcellular localization of newly discovered BIA biosynthetic enzymes will be determined, and possible enzyme interactions will also be investigated.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
183573-2009
Name nom
Facchini, Peter
Department département
Biological Sciences
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
71000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
3
Committee name en
Plant Biology & Food Science
Committee name fr
Biol vég/sc alimentaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
4900
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Plant and treebiology
Research subject fr
Biologie végétale et des arbres
Partie
4
Nb partie
7
Application title
Intergrated biochemical genomics and cellular platform for alkaloid biosynthetic gene discovery and characterization
Keyword
NSERC
Application summary
The unparalleled biosynthetic capacity of plants has long been exploited through the use of many species in traditional medicine and the application of pure metabolites as pharmaceuticals, flavours, fragrances, pigments, insecticides, and other fine chemicals. Benzylisoquinoline alkaloids (BIAs) are a large group of plant specialized metabolites derived from tyrosine and diversified by an intricate biochemical network of intramolecular coupling, reduction, methylation, hydroxylation, and other reactions that generate >2,500 known structures. Several BIAs (e.g. the analgesic morphine, the cough suppressant codeine, and the vasodilators papaverine and tubocurarine) serve directly as pharmaceuticals, or as precursors for semi-synthetic drugs (e.g. oxycodone). Plants remain the only economical source for these compounds due to their chemical complexity, which makes de novo synthesis challenging and costly. Most research on BIA metabolism has targeted biosynthetic enzymes and corresponding genes involved in the formation of relatively few compounds in only a limited number of species. An important feature of plant specialized metabolism is the ability of enzymes to acquire novel functions through random mutation. As such, a relatively limited number of enzyme types (i.e. SAM-dependent methyltransferases, acetylCoA-dependent acyltransferases, P450-dependent monooxygenases, FAD-dependent oxidoreductases, short-chain dehydrogenase/reductases and aldo-keto reductases) are largely responsible for the establishment of the diverse backbone structures and functional group substitutions responsible for BIA structural diversity. A functional genomics strategy based on the integration and comparison of metabolite and transcript profiles from a collection of cultured plant species will be used to identify and characterize novel BIA biosynthetic enzymes. Genomics resources and molecular genetic tools will be used to identify and modulate transcription factors involved in the regulation of BIA metabolism. The cellular and subcellular localization of newly discovered BIA biosynthetic enzymes will be determined, and possible enzyme interactions will also be investigated.